The attached submission, presented to the Trade Policy Staff Committee of the Executive Office of the President on behalf of PhRMA and its member companies, identifies significant barriers to the export of goods, services and overseas direct investment for for inclusion in the 2017 National Trade Estimate Report (NTE).